OPTH logo

OPTIMI HEALTH CORP

OPTHNASDAQ
US Equity
$2.79—
Last available close · quote unavailable
🔔
Track OPTH
Get earnings, price moves & breaking news on Telegram
Track
24h—
7d▼ 19.4%
14d▼ 11.4%
30d▼ 41.6%
ytd—
1y—
🏦Market Cap
—
📈Revenue Growth (YoY)
-57.8%
Declining
📊Gross Margin
65.1%
High
💵FCF Margin
—
⚖️P/S Ratio
101.5x
Expensive
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
—
52-Week Range
—
Volume (shares)
—
Avg Volume (shares)
—
Shares Outstanding
5.7M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$426,904
Last Q Revenue
$98,700
P/E Ratio
—
P/S Ratio
101.5x
EPS (TTM)
—
Dividend Yield
—
Dilution (1yr)
+7.9%
OPTH logo

OPTIMI HEALTH CORP

OPTH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$427K▲ +9.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-486.4%▼ −800.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$5M▼ −19.2% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$3M▼ −38.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
3.2M▲ +7.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$6M▼ −$3M YoY
StockOtter · stockotter.space

About OPTIMI HEALTH CORP

Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.